ArticleLeukemia2008

MAGE-C1/CT7 is the dominant cancer-testis antigen targeted by humoral immune responses in patients with multiple myeloma.

A Curioni-Fontecedro et al.PubMed ↗Publisher ↗

No numbers read from the abstract.